Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIAsource ImmunoAssays has over three decades of experience in developing and commercializing high-quality IVD assays—primarily ELISA and RIA kits—and antibodies/antigens for clinical diagnostics. Their portfolio covers endocrinology, autoimmunity and infectious disease testing. The company maintains ISO certifications and supplies both manual and automated solutions to laboratories worldwide. Since its acquisition by BioVendor Group the product range has expanded further.
No clinical trial results as the company does not develop therapeutics.
Products are CE-IVD marked; quality management system certified under ISO9001/ISO13485/MDSAP/FDA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIAsource ImmunoAssays.